EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer [2] (multiple letters)
Journal
New England Journal of Medicine
Journal Volume
353
Journal Issue
2
Pages
207-208
Date Issued
2005
Author(s)
SDGs
Other Subjects
cisplatin; epidermal growth factor receptor; gefitinib; gemcitabine; antineoplastic agent; gefitinib; protein kinase inhibitor; quinazoline derivative; adult; anamnesis; brain tumor; cancer radiotherapy; case report; clinical feature; female; gene mutation; human; laboratory test; letter; lung adenocarcinoma; lung non small cell cancer; priority journal; radiosurgery; stereotaxic surgery; drug resistance; genetics; lung non small cell cancer; lung tumor; middle aged; point mutation; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Middle Aged; Point Mutation; Protein Kinase Inhibitors; Quinazolines; Receptor, Epidermal Growth Factor
Type
letter